S
PBYI icon

SignatureFD’s Puma Biotechnology PBYI Stock Holding History

SignatureFD’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.98K Buy
+367
New +$2.69K ﹤0.01% 3038
2016
Q1 		– Sell
-29
Closed -$2K – 1428
2015
Q4 		$2K Buy
29
+7
+32% +$549 ﹤0.01% 1103
2015
Q3 		$2K Buy
+22
New +$2.08K ﹤0.01% 1040

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SignatureFD's PBYI Position: Q2 2026 in Review

SignatureFD opened a new position in Puma Biotechnology (PBYI) in Q2 2026: 367 shares worth $2.98K. The stake represents ﹤0.01% of the portfolio and ranks #3038 among its holdings. This is a return to the name: SignatureFD previously reported a position in PBYI as recently as Q4 2015.

SignatureFD first reported a position in PBYI in Q3 2015 and has held it in 3 quarters since. 160 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.

  • SignatureFD held 367 shares of Puma Biotechnology worth $2.98K as of Q2 2026.
  • Puma Biotechnology was a new SignatureFD position in Q2 2026.
  • Puma Biotechnology made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #3038 holding.
  • SignatureFD first reported a position in Puma Biotechnology in Q3 2015 and has held it in 3 quarters since.
  • 160 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.